Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Lung Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Colorectal Neoplasms 2 Smoking Cessation 1 Sedentary Behavior 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Pain 1 Myelodysplastic Syndromes 1 Motor Activity 1 Metastatic Pancreatic Adenocarcinoma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphoid System Neoplasm 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Chronic Pain 1 Chronic Disease 1 Cervical Cancer Screening 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 COVID-19 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Alzheimer Disease 1 Agnosia 1

Interventions

Bupivacaine 4 Saline Solution 3 Ketamine 3 Transcutaneous Electric Nerve Stimulation 2 Ropivacaine 2 Radiofrequency Ablation 2 Magnesium Sulfate 2 Ketorolac 2 Dexmedetomidine 2 Control Groups 2 Anesthesia, Local 2 Acupuncture Therapy 2 Acetaminophen 2 engage 8200 1 Yoga 1 Varenicline 1 Transdermal Patch 1 Therapeutics 1 Telemedicine 1 Surgical Instruments 1 STAMP-I protocol 1 Radiosurgery 1 Psilocybin 1 Palliative Care 1 Oxycodone 1 Music Therapy 1 Morphine 1 Methods 1 Levobupivacaine 1 Ketoprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Telemedicine × 1 year × Clear all

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡